Journal of Clinical Immunology Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Commentary - Journal of Clinical Immunology Research (2022) Volume 5, Issue 2

Pemphigoid diseases: Role of immune cells?

The presence of different types of antibodies and the phenotypic location of the disease are used to classify pemphigoid disease. Patients with bullous pemphigoid and mucous membrane pemphigoid are more likely to have ocular pemphigoid. Pemphigoid illness is caused by a variety of immune cells, including those from the innate and adaptive immune systems. Pemphigoid is still treated in a variety of ways, with immunosuppressants and corticosteroids being the most common. In this case, it's critical to screen the immune cells participating in this category of disorders and evaluate whether a tailored treatment approach is feasible. Finally, this analysis will highlight some newer therapeutic options for pemphigoid illnesses across the board.

Author(s): Daniel Reed

Abstract Full Text PDF

Get the App